References
1. Kass M, Arya VK, Shah AH. COVID-19-Positive Patient and Hypoxemia: Are Lungs Always to Be Blamed? JACC Cardiovasc Interv. 2021;14:e101-e102.
2. Vanhomwegen C, Taton O, Selvais N, et al. Patent foramen ovale revealed by COVID-19 pneumonia. BMC Pulmonary Medicine. 2021;21:126.
3. Rigatelli G, Zuin M. Managing patent foramen ovale in COVID-19 patients during and after viral infection: an unresolved matter. J Cardiovasc Med (Hagerstown). 2021;22:259-260.
4. Rajendram R, Kharal GA, Mahmood N, et al. Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization. Thromb Res. 2020;196:206-208.
5. Fisher HK. Hypoxemia in COVID-19 patients: An hypothesis. Med Hypotheses. 2020;143:110022.
6. Trifi A, Ouhibi A, Mahdi A, et al. Shunt in critically ill Covid-19 ARDS patients: Prevalence and impact on outcome (cross-sectional study). Journal of Critical Care. 2022;70:154048.
7. Shah R, Nayyar M, Jovin IS, et al. Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke: A Systematic Review and Meta-analysis. Ann Intern Med. 2018;168:335-342.
8. Musuku SR, Srikanthan A, Cherukupalli D, et al. NobleStitch EL PFO Closure Guided by Transesophageal Echocardiography. J Cardiothorac Vasc Anesth. 2020.
9. Gaspardone A, De Marco F, Sgueglia GA, et al. Novel percutaneous suture-mediated patent foramen ovale closure technique: early results of the NobleStitch EL Italian Registry. EuroIntervention. 2018;14:e272-e279.
10. Gaspardone A, Sgueglia GA, De Santis A, et al. Predictors of Residual Right-to-Left Shunt After Percutaneous Suture-Mediated Patent Fossa Ovalis Closure. JACC Cardiovasc Interv. 2020;13:2112-2120.
11. Zannoni J, Popolo Rubbio A, Tusa MB, et al. Mechanisms of ineffective patent foramen ovale closure using the percutaneous suture-mediated NobleStitch system. EuroIntervention. 2022.
12. Prospective Multi Center Comparative Parallel Concurrent Study of the NobleStitch EL Compared to FDA Approved Amplatzer Occluder Device for Closure of Patent Foramen Ovale to Prevent Recurrent Ischemic Stroke; Available at: https://clinicaltrials.gov/ct2/show/NCT04339699?term=noblestitch&draw=2&rank=1. Accessed March, 2022.
13. Ashraf M, Sajed S. Acute Stroke in a Young Patient With Coronavirus Disease 2019 in the Presence of Patent Foramen Ovale. Cureus. 2020;12:e10233.
14. Nopp S, Moik F, Jilma B, et al. Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis. Res Pract Thromb Haemost. 2020;4:1178-1191.
15. Scoccia A, Laricchia A, Ielasi A, et al. TCT-479 Percutaneous Suture-Based Closure of Patent Foramen Ovale: Initial Results of a Multicenter Experience in a Highly Selected Population. J Am Coll Cardiol. 2021;78:B197-B197.